CUSIP: 67080N101
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Total 13F shares
-
159,104,350
-
Share change
-
+3,821,085
-
Total reported value
-
$836,898,347
-
Price per share
-
$5.26
-
Number of holders
-
112
-
Value change
-
+$14,198,236
-
Number of buys
-
53
-
Number of sells
-
41
Quarterly Holders Quick Answers
What is CUSIP 67080N101?
CUSIP 67080N101 identifies NUVB - Nuvation Bio Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2022
-
Previous quarter:
Q4 2021
Recent filing periods for CUSIP 67080N101:
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q1 2022
As of 31 Mar 2022,
Nuvation Bio Inc. - Common Stock (NUVB) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
159,104,350 shares.
The largest 10 holders included
FMR LLC, Omega Fund Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., BAUPOST GROUP LLC/MA, CITADEL ADVISORS LLC, Avidity Partners Management LP, BOXER CAPITAL, LLC, and ABRAMS CAPITAL MANAGEMENT, L.P..
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.